Neuralink Patients Steer Wheelchairs With Their Thoughts

FREMONT, Calif. — Neuralink has taken its brain-computer interface a major step closer to restoring independence, with trial participants now steering powered wheelchairs using only their thoughts. Elon Musk highlighted the progress in a demonstration showing physically impaired users moving forward and back, turning, and adjusting their seats as they navigated indoor rooms and outdoor paths.

From cursor to real-world mobility

The wheelchair work builds directly on the technology that first let people with paralysis move a computer cursor. Neuralink says its N1 implant uses 1,024 electrodes placed in the motor cortex to detect neural activity tied to intended movement. A machine-learning model translates those signals into commands that drive the chair through a live camera feed, letting users reverse, steer and reposition the seat and backrest.

Safety is built into the system. Neuralink says an automatic return-to-center feature slows and stops the chair when a user loses focus, an important safeguard as the company pushes decoded intent into devices that move through the physical world. It is the same decoding foundation the company has been extending across tasks, including the robotic-arm control demonstrated in its CONVOY trial.

A growing clinical footprint

The milestone arrives as Neuralink's trials expand quickly. The company has now implanted its device in more than two dozen participants across several countries, up from 21 earlier in the year, with separate studies running internationally. Each new participant adds data that sharpens the decoding models and widens the range of tasks the implant can handle.

For users, the promise is concrete. Powered-wheelchair control is a far stronger test of real independence than moving a cursor, because it restores the ability to move through a home or down a street without a caregiver operating the controls. Musk described the implant as a way to help those who have lost the connection between mind and body to regain it.

What comes next

Neuralink frames the wheelchair demonstration as a research milestone rather than a finished product. The N1 implant has not yet received full U.S. Food and Drug Administration approval, and the company continues to gather safety and performance data through its ongoing studies, as reported by Interesting Engineering.

Still, the trajectory is clear. In a matter of years, Neuralink has moved from a single participant controlling a cursor to multiple users steering wheelchairs, operating robotic arms and working toward speech decoding. Each capability points to the same goal: giving people with paralysis practical, everyday control over the world around them, and a growing measure of the independence that injury or illness took away.